The Needle-Free Injectors Market Size is valued at 140.4 Million in 2022 and is predicted to reach 614.8 Million by the year 2031 at a 17.90 % CAGR during the forecast period for 2023-2031.
Needle-free injectors are an innovative way to introduce various medicines into patients without piercing the skin with a traditional needle. Needle-free injection systems are safer, effective, and more suitable as compared to conventional needles. These systems are available in different forms, such as power sprays, edible products, inhalers, and skin patches. Usage of these injectors can reduce the number of needle stick accidents and associated problems.
The growing demand for self-injection devices, advanced medical infrastructure, growing geriatric population, rising prevalence of chronic and infectious diseases, lack of reusability of traditional needles, increasing healthcare expenditures, and the rising need for vaccination are the major driving factors of the needle-free injectors market. Pharmaceutical companies focus on developing advanced, safe, and pain-free injectors to fulfill the growing demand for self-injection devices. Therefore, launching new quality products in the market is expected to fuel the growth of the needle-free injectors market during the forecast period. However, the high manufacturing cost of needle-free injections and the lack of trained personnel are likely to limit the market growth during the forecast period.
The needle-free injectors market is classified based on applications, load, technology, end-users, delivery site, usage, and region. The applications segment comprises drug delivery, vaccines, cosmetics, and other applications. The drug delivery segment is expected to dominate this market in the near future due to the rising chronic diseases and geriatric population. By load, the market is segmented into liquid injections, powder injections, projectile injections. The liquid segment is anticipated to hold a significant market share in the coming days due to its rapid administration and flexible nature. By technology, the market is classified into spring-loaded jet injectors, battery-powered jet injectors, gas-powered jet injectors. The market comprises hospitals, veterinary hospitals, specialty clinics, home care settings, and other end-users based on end-users.
The market is grouped into intradermal injectors, intramuscular injectors, and subcutaneous injectors in terms of delivery site. The subcutaneous injectors segment is expected to grow rapidly over the forecast years due to its speed and low cost. Based on the usage, the market is segmented into reusable needle-free injectors and disposable needle-free injectors. Geographically, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East, and Africa. North America is expected to hold the highest share of this market during the forecast period, followed by Europe due to the high prevalence of chronic diseases and the advancement of medical technologies.
Report Attribute |
Specifications |
Market Size Value In 2022 |
USD 140.4 Million |
Revenue Forecast In 2031 |
USD 614.8 Million |
Growth Rate CAGR |
CAGR of 17.90 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Applications, By Type, By Product, By Technology, By End-Users, By Delivery Site, By Usage |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Pfizer (US), Antares Pharma, Inc. (US), Injex UK (UK), Gaungzhou Medsinglong Medical Equipment Company Ltd. (China), Zogenix (US), D'Antonio Consultants International, Inc. (US), AcuShot Needle Free (Canada), InsuJet (The Netherlands), QS Medical Technology Co., Ltd (China), MIKA MEDICAL CO. (South Korea), and Others |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Global Needle-Free Injectors Market, by Applications, Value (US$ Mn) and Volume (No. of Units)
Global Needle-Free Injectors Market, by type, Value (US$ Mn) and Volume (No. of Units)
Global Needle-Free Injectors Market, by Technology, Value (US$ Mn) and Volume (No. of Units)
Global Needle-Free Injectors Market, by End-Users, Value (US$ Mn) and Volume (No. of Units)
Global Needle-Free Injectors Market, by Delivery Site, Value (US$ Mn) and Volume (No. of Units)
Global Needle-Free Injectors Market, by Usage, Value (US$ Mn) and Volume (No. of Units)
Global Needle-Free Injectors Market, by Region, Value (US$ Mn) and Volume (No. of Units)
North America Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)
Europe Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)
Asia Pacific Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)
Latin America Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)
Middle East & Africa Needle-Free Injectors Market, by Country, Value (US$ Mn) and Volume (No. of Units)
Competitive Landscape
Latest Strategic Developments
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.